Adam Smith Conferences

A practical Panel Session on the Commercialization of Pharmaceutical Products, exploring how marketing and digital technologies are transforming pharma promotion — from online-offline integration and AI-driven personalization to digital channels (e-commerce, social media, mobile apps), CRM-based sales automation, and personalized engagement with doctors and pharmacies, while navigating advertising restrictions and personal data regulations.

MARINA DURMANOVA, President, Association for the Support and Development of Pharmaceutical Activities of the Republic of Kazakhstan
LARISSA YEMELYANOVA, Partner, AEQUITAS Law Firm
ZHANNA KUNEKBAYEVA, General Director, Sona-Pharm Kazakhstan
EVGENIY TIKHONOV, Head of Sales, Dazur KZ
ALEXANDER BEZBORODOV, Attorney-at-law, Partner, LL.M., ADVANT Beiten
IVAN MEDVEDEV, Executive Director, Apteka So Sklada

Yesterday, a dynamic panel session on pricing and economic efficiency was held in the pharmaceutical industry. The session explored pricing models across the EAEU and CIS, high-cost therapy financing, the complexities of reference pricing, and pathways towards a unified pricing approach, all while balancing the interests of patients, the state and businesses.

VYACHESLAV LOKSHIN, President, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan
YERLAN ALZHAN, Deputy Chairman, Agency for Protection and Development of Competition of the Republic of Kazakhstan
ZAFAR VAKHIDOV, Partner, Vakhidov & Partners
ANASTASIIA KINGSHOTT, Head of Department for Health Technology Assessment, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
VICTORIA VYUSHKOVA, Head of CIS, Astellas
ANDREY IVANOV, Head of Market Access Department, Kazakhstan, AstraZeneca
ANDREY KOLESNIKOV, Sr. Director of External Communications, Government Affairs & Market Access, Russia and Eurasia, Teva

The Plenary Session “State and Business: Creating Conditions for Industry Development” brought together government representatives and industry experts to discuss legislative changes, EAEU harmonization, localization and innovation support, investment climate improvements, and medicine supply across CIS countries.

We thank the moderator and speakers for a substantive and constructive dialogue on the future of the pharmaceutical sector.
Arevik Markaryan — Head of Strategic Sectors Department, Ministry of Economy of the Republic of Armenia
Elena Maksimkina — Director, Federal Center for Planning and Organization of Drug Provision for Citizens, Ministry of Health of the Russian Federation
Marat Kaliyev — International Expert, State Medical Insurance Fund of the Republic of Uzbekistan
Rafik Khudayev — Deputy Director General, Analytical Expertise Center, Ministry of Health of the Republic of Azerbaijan
Asel Esenalieva — Head of the Department of Drug Expertise, Department of Drugs and Medical Devices, Ministry of Health of the Kyrgyz Republic
Uldan Derbisbekova — Head of the Department of Drug Expertise, National Center for Drug and Medical Device Expertise

The discussion highlighted the importance of coordinated efforts between the state and business to create a sustainable, transparent, and innovation-driven pharmaceutical market across the region.

We have just concluded an open dialogue as part of the Plenary Discussion: “The Eurasian Pharma Market: The Industry’s View on Challenges and Prospects”, held during Eurasian Pharma 2026.

Many of the questions raised continue to carry over from year to year — yet they clearly demand fresh approaches and new solutions. The discussion was candid, dynamic, and highly relevant to the realities facing the pharmaceutical industry across the region.

A sincere thank you to our outstanding speakers for their insights, expertise, and openness:

Moderator:
Vyacheslav Lokshin — President, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan

Speakers:
Sofia Yatsko — Deputy Director for Public Relations and Market Access, GEROPHARM
Elena Lee — Founder of Dolce Group, President of AIID
Adilet Nazarbayev — General Director, Johnson & Johnson Kazakhstan
Zaituna Salmanova — Operations Director of Business Processes in the CauCAR region, Pfizer
Olzhas Satybaldin — Head of Government Relations, Russia and Eurasia, AstraZeneca
Pavel Khegay — General Director, Gedeon Richter Kazakhstan, Chairman of the Health Committee, EUROBAK

Thank you to everyone who contributed to this meaningful exchange. The conversation continues — and so does the search for practical, forward-looking solutions for the Eurasian pharmaceutical market.